Vaxcyte, Inc (PCVX)
63.31
-2.92 (4.41%)
Upcoming Events
Latest Headlines
Vaxcyte (PCVX) Reiterated at Overweight by Cantor Fitzgerald Afters OPUS-1 Top Line
October 19, 2026 7:29 AM - StreetInsider
Vaxcyte (PCVX) PT Set at $120 at Cantor Fitzgerald - Pressure on Shares Explained by Challenging Market
October 12, 2026 7:10 AM - StreetInsider
Form 8-K Vaxcyte, Inc. For: Oct 06
October 9, 2026 4:43 PM - SEC Filing
Vaxcyte closes $1.15B public offering of stock and notes
October 9, 2026 4:05 PM - StreetInsider
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional
October 9, 2026 4:05 PM - StreetInsider
Form 424B5 Vaxcyte, Inc.
October 8, 2026 4:35 PM - SEC Filing
Form 424B5 Vaxcyte, Inc.
October 8, 2026 4:31 PM - SEC Filing
Form 4 Vaxcyte, Inc. For: Oct 05 Filed by: Wassil Jim
October 7, 2026 4:09 PM - SEC Filing
Form 4 Vaxcyte, Inc. For: Oct 05 Filed by: Cowan Elvia
October 7, 2026 4:08 PM - SEC Filing
Form FWP Vaxcyte, Inc. Filed by: Vaxcyte, Inc.
October 7, 2026 6:05 AM - SEC Filing
Vaxcyte prices $1B in stock and note offerings
October 6, 2026 10:48 PM - StreetInsider
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
October 6, 2026 10:48 PM - Globe NewsWire
Vaxcyte (PCVX) PT Raised to $146 at BofA Securities
October 6, 2026 6:08 AM - StreetInsider
Form 424B5 Vaxcyte, Inc.
October 6, 2026 6:02 AM - SEC Filing
Form 305B2 Vaxcyte, Inc.
October 6, 2026 6:02 AM - SEC Filing
Form 424B5 Vaxcyte, Inc.
October 6, 2026 6:02 AM - SEC Filing
Vaxcyte launches $1B in dual public offerings of stock and notes
October 5, 2026 4:28 PM - StreetInsider
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
October 5, 2026 4:28 PM - StreetInsider
Form 144 Vaxcyte, Inc. Filed by: Cowan Elvia
October 5, 2026 4:11 PM - SEC Filing
Form 144 Vaxcyte, Inc. Filed by: Wassil Jim
October 5, 2026 4:10 PM - SEC Filing
BTIG Reiterates Buy Rating on Vaxcyte (PCVX)
October 5, 2026 1:38 PM - StreetInsider
Vaxcyte (PCVX) PT Raised to $122 at Needham
October 5, 2026 1:28 PM - StreetInsider
Biotech Brainiacs and Breakthroughs
October 5, 2026 9:52 AM - StreetInsider
Form 8-K Vaxcyte, Inc. For: Oct 05
October 5, 2026 8:01 AM - SEC Filing
Vaxcyte stock soars 50% on positive phase 3 vaccine data
October 5, 2026 7:20 AM - StreetInsider
Vaxcyte (PCVX) PT Raised to $125 at Guggenheim
October 5, 2026 6:23 AM - StreetInsider
Vaxcyte's VAX-31 vaccine meets all phase 3 trial endpoints
October 5, 2026 6:00 AM - StreetInsider
Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
October 5, 2026 6:00 AM - StreetInsider
Vaxcyte to release Phase 3 trial data for VAX-31 vaccine candidate
October 4, 2026 5:00 PM - StreetInsider
Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
October 4, 2026 5:00 PM - StreetInsider
Form 4 Vaxcyte, Inc. For: Oct 01 Filed by: Wassil Jim
October 2, 2026 4:07 PM - SEC Filing
Form 144 Vaxcyte, Inc. Filed by: Wassil Jim
October 1, 2026 4:13 PM - SEC Filing
Vaxcyte (PCVX) PT Lowered to $130 at BofA Securities
September 28, 2026 6:04 AM - StreetInsider
Vaxcyte names new CMO, CLO and narrows VAX-31 data timeline
September 3, 2026 4:05 PM - StreetInsider
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
September 3, 2026 4:05 PM - StreetInsider
Vaxcyte to Participate in Upcoming Investor Conferences
August 27, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: Janus Henderson Group Ltd.
August 11, 2026 2:24 PM - SEC Filing
Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: Janus Henderson Group Ltd.
August 7, 2026 12:52 PM - SEC Filing
Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: FMR LLC
August 6, 2026 10:44 AM - SEC Filing
Form 4 Vaxcyte, Inc. For: Aug 05 Filed by: Dhaliwal Harpreet S.
August 5, 2026 7:02 PM - SEC Filing
Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 7c
August 5, 2026 6:23 PM - StreetInsider
Form 4 Vaxcyte, Inc. For: Aug 03 Filed by: Wassil Jim
August 5, 2026 4:59 PM - SEC Filing
Form 4 Vaxcyte, Inc. For: Aug 03 Filed by: GUGGENHIME ANDREW
August 5, 2026 4:58 PM - SEC Filing
Form 10-Q Vaxcyte, Inc. For: Jun 30
August 5, 2026 4:17 PM - SEC Filing
Form 8-K Vaxcyte, Inc. For: Aug 05
August 5, 2026 4:12 PM - SEC Filing
Form 144 Vaxcyte, Inc. Filed by: Dhaliwal Harpreet S.
August 5, 2026 4:07 PM - SEC Filing
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026 4:05 PM - Globe NewsWire
Form 144 Vaxcyte, Inc. Filed by: GUGGENHIME ANDREW
August 3, 2026 4:16 PM - SEC Filing
Form 144 Vaxcyte, Inc. Filed by: Wassil Jim
August 3, 2026 4:15 PM - SEC Filing
Form 4 Vaxcyte, Inc. For: Jul 27 Filed by: PICKERING GRANT
July 28, 2026 4:11 PM - SEC Filing
Form 144 Vaxcyte, Inc. Filed by: PICKERING GRANT
July 27, 2026 4:18 PM - SEC Filing
Full Article List
